These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 33423267)

  • 1. [Association of CYP2C19 and CYP3A5 gene polymorphisms with myocardial infarction].
    Qi L; Liang W; Qiao H; Wang R; Han J; Xing X; Hu Y
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2021 Jan; 38(1):87-91. PubMed ID: 33423267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Analysis of the association of CYP450 gene polymorphisms with ischemic stroke].
    Qi L; Liu Y; Qi M; Peng Y; Sun G; Yue Y
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2023 Apr; 40(4):500-504. PubMed ID: 36972950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Correlation between CYP2C19 Gene Polymorphism and Elderly Cerebral Infarction].
    Fan DJ; Li CY; Chen J; Ye ZQ
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2018 Dec; 40(6):765-768. PubMed ID: 30606386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional polymorphisms in CYP2C19 & CYP3A5 genes associated with decreased susceptibility for paediatric tuberculosis.
    Feng WX; Liu F; Gu Y; Jiao WW; Sun L; Xiao J; Wu XR; Miao Q; Shen C; Shen D; Shen A
    Indian J Med Res; 2012 May; 135(5):642-9. PubMed ID: 22771593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of Cytochrome P450 Genetic Variants with Clopidogrel Resistance and Outcomes in Acute Ischemic Stroke.
    Yi X; Lin J; Wang Y; Zhou Q; Wang C; Cheng W; Chi L
    J Atheroscler Thromb; 2016 Oct; 23(10):1188-1200. PubMed ID: 26961113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of
    Liang Y; Han W; Yan H; Mao Q
    J Cancer Res Ther; 2018 Jun; 14(Supplement):S463-S467. PubMed ID: 29970707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of
    Wang D; Yong L; Zhang Q; Chen H
    Pharmacogenomics; 2022 Nov; 23(16):903-911. PubMed ID: 36222113
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmacogenetic relevant polymorphisms of CYP2C9, CYP2C19, CYP2D6, and CYP3A5 in Bhutanese population.
    Dorji PW; Wangchuk S; Boonprasert K; Tarasuk M; Na-Bangchang K
    Drug Metab Pers Ther; 2019 Dec; 34(4):. PubMed ID: 32004143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CYP2C19-rs4986893 confers risk to major depressive disorder and bipolar disorder in the Han Chinese population whereas ABCB1-rs1045642 acts as a protective factor.
    Zhang T; Rao Q; Lin K; He Y; Cai J; Yang M; Xu Y; Hou L; Lin Y; Liu H
    BMC Psychiatry; 2023 Jan; 23(1):69. PubMed ID: 36698099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The influence of CYP2C19*2 and CYP3A5*3 variants on the development of depression and effectiveness of therapy: A preliminary study.
    Świechowski R; Jeleń A; Pietrzak J; Gałecki P; Szmajda-Krygier D; Balcerczak E
    Biomed Pharmacother; 2021 Oct; 142():112055. PubMed ID: 34435592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concomitant Use of Proton Pump Inhibitors and Clopidogrel Is Not Associated with Adverse Outcomes after Ischemic Stroke in Chinese Population.
    Yi X; Zhou Q; Wang C; Lin J; Cheng W; Chi L
    J Stroke Cerebrovasc Dis; 2016 Dec; 25(12):2859-2867. PubMed ID: 27546731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of genetic polymorphisms of P2Y12, CYP3A5 and CYP2C19 on clopidogrel response variability in Iranian patients.
    Namazi S; Kojuri J; Khalili A; Azarpira N
    Biochem Pharmacol; 2012 Apr; 83(7):903-8. PubMed ID: 22265638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of the new proton pump inhibitor ilaprazole in Chinese healthy subjects in relation to CYP3A5 and CYP2C19 genotypes.
    Li Y; Zhang W; Guo D; Zhou G; Zhou H; Xiao Z
    Clin Chim Acta; 2008 May; 391(1-2):60-7. PubMed ID: 18319058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CYP2C19 gene polymorphism in Ningxia.
    Yang Z; Xie Y; Zhang D; Zou Y; Li X; Chen R; Zhang X; Chen S; Bai F
    Pharmacol Rep; 2023 Jun; 75(3):705-714. PubMed ID: 36913175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distribution of ABCB1, CYP3A5, CYP2C19, and P2RY12 gene polymorphisms in a Mexican Mestizos population.
    Vargas-Alarcón G; Ramírez-Bello J; de la Peña A; Calderón-Cruz B; Peña-Duque MA; Martínez-Ríos MA; Ramírez-Fuentes S; Pérez-Méndez O; Fragoso JM
    Mol Biol Rep; 2014 Oct; 41(10):7023-9. PubMed ID: 25106522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of CYP2C19 and CYP3A5 genetic polymorphisms on the pharmacokinetics of cilostazol and its active metabolites.
    Lee HI; Byeon JY; Kim YH; Lee CM; Choi CI; Jang CG; Bae JW; Lee YJ; Lee SY
    Eur J Clin Pharmacol; 2018 Nov; 74(11):1417-1426. PubMed ID: 30039199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carriage of cytochrome 2C19 polymorphism is associated with risk of high post-treatment platelet reactivity on high maintenance-dose clopidogrel of 150 mg/day: results of the ACCEL-DOUBLE (Accelerated Platelet Inhibition by a Double Dose of Clopidogrel According to Gene Polymorphism) study.
    Jeong YH; Kim IS; Park Y; Kang MK; Koh JS; Hwang SJ; Kwak CH; Hwang JY
    JACC Cardiovasc Interv; 2010 Jul; 3(7):731-41. PubMed ID: 20650435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of the Potential Association of Drug-Metabolizing Enzymes
    Elfaki I; Mir R; Abu-Duhier FM; Jha CK; Ahmad Al-Alawy AI; Babakr AT; Habib SAE
    Curr Drug Metab; 2020; 21(14):1152-1160. PubMed ID: 33115391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Genetic Polymorphism of CYP3A5 and CYP2C19 and Concomitant Use of Voriconazole on Blood Tacrolimus Concentration in Patients Receiving Hematopoietic Stem Cell Transplantation.
    Iwamoto T; Monma F; Fujieda A; Nakatani K; Gayle AA; Nobori T; Katayama N; Okuda M
    Ther Drug Monit; 2015 Oct; 37(5):581-8. PubMed ID: 25565672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of CYP2C19, CYP3A4, ABCB1, and FMO3 genotypes on plasma voriconazole in Thai patients with invasive fungal infections.
    Chuwongwattana S; Jantararoungtong T; Prommas S; Medhasi S; Puangpetch A; Sukasem C
    Pharmacol Res Perspect; 2020 Dec; 8(6):e00665. PubMed ID: 33124772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.